Last update 22 Aug 2026

RDH12 gene therapy (MeiraGTx)

Overview

Basic Info

Drug Type
AAV based gene therapy
Synonyms
AAV5-RDH12, AAV-RDH12
Target
RDH12
Action
modulators
Mechanism
RDH12 modulators(retinol dehydrogenase 12 modulators), Gene transference(Gene transference)
Therapeutic Areas
Congenital DisordersEye DiseasesOther Diseases
Active Indication-
Inactive Indication
Leber Congenital AmaurosisRetinal Dystrophies
Originator Organization
MeiraGTx Ltd.
Active Organization-
Inactive Organization
MeiraGTx Holdings PlcMeiraGTx Holdings Plc
License Organization-
Drug Highest PhaseDiscontinuedPreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with RDH12 gene therapy (MeiraGTx)
Login to view more data
100 Translational Medicine associated with RDH12 gene therapy (MeiraGTx)
Login to view more data
100 Patents (Medical) associated with RDH12 gene therapy (MeiraGTx)
Login to view more data
100 Deals associated with RDH12 gene therapy (MeiraGTx)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Leber Congenital AmaurosisPreclinical
United States
MeiraGTx Holdings PlcMeiraGTx Holdings Plc
01 Feb 2022
Retinal DystrophiesPreclinical
United States
MeiraGTx Holdings PlcMeiraGTx Holdings Plc
01 Feb 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free